این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Heart Journal، جلد ۱۸، شماره ۲، صفحات ۴۳-۴۹
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Fibrinolytic Therapy With Streptokinase vs Tenecteplase for Patients With ST-Elevation MI Not Amenable to Primary PCI
چکیده انگلیسی مقاله Background: Although primary percutaneous intervention (PCI) is the preferred reperfusion strategy in patients with STEMI, not all patients are good candidates for PCI-mainly because of a delay in requesting medical care and longer 1st medical contact to balloon time. The objective of this study was to compare the efficacy and side effects of 2 known fibrinolytic therapies, streptokinase (SK) and tenecteplase (TNK). Methods: This descriptive, analytic cross-sectional study recruited patients not amenable to primary PCI. a total of 142 patients recruited, 88 patients received SK and the other 54 patients received TNK. Thereafter, the efficacy of the agents, their side effects, territory of the culprit vessel, minor and major bleeding, relation to diabetes mellitus, and mortality in the index hospitalization were compared. Results: Patients who were administered SK showed a 2.09-mm ST elevation after the drug administration as opposed to 1.95 mm in the TNK group (P=0.340). Minor bleeding was reported in 22.7% of the SK group and 24.1% in the TNK group. Major bleeding in the SK and TNK groups was 11.1% and 5.7%, respectively, with no significant difference. In the patients' index admission, death due to STEMI occurred in 10 (11.4%) patients in the SK group and 8 (14%) patients in the TNK group; the difference did not constitute statistical significance. Conclusions: The results of our study showed that SK and TNK were similar in terms of major complications, mortality rates, and efficacy. Thus, if TNK is not available, SK would be a reasonable choice. (Iranian Heart Journal 2017; 18(2):43-49)
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله Amir Hossein Yazdi |
School of Medicine, Hamedan University of Medical Sciences, Hamedan, I.R.Iran.

Ehsan Khalilipur |
Rajaie Cardiovascular, Medical,and Research Center, Iran University of Medical Sciences, Tehran, I.R.Iran.

Ali Zahedmehr |
Cardiovascular Intervention Research Center, Rajaie Cardiovascular,Medical,and Research Center, Iran University of Medical Sciences, Tehran, I.R.Iran

Saeed Amiri Pouya |
Rajaie Cardiovascular, Medical,and Research Center, Iran University of Medical Sciences, Tehran, I.R.Iran

Maryam Pakrou |
Rajaie Cardiovascular, Medical,and Research Center, Iran University of Medical Sciences, Tehran, I.R.Iran

Mohammad Ali Ghaznavi |
Rajaie Cardiovascular, Medical,and Research Center, Iran University of Medical Sciences, Tehran, I.R.Iran

Amir Mikaelvand |
Rajaie Cardiovascular, Medical,and Research Center, Iran University of Medical Sciences, Tehran, I.R.Iran

Mostafa Rouzitalab |
Rajaie Cardiovascular, Medical,and Research Center, Iran University of Medical Sciences, Tehran, I.R.Iran

نشانی اینترنتی http://journal.iha.org.ir/article_83119_277db883aae4eb751b3aeafe45d55d84.pdf
فایل مقاله اشکال در دسترسی به فایل - ./files/site1/rds_journals/162/article-162-1423906.pdf
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات